Neuromyelitis optica

Apr 21, 2020

Harbour BioMed Announces First Patient Dosing of Phase 1b/2a Study of Anti-FcRn Batoclimab for Treating Neuromyelitis Optica Spectrum Disorder

Feb 12, 2020

Prevalence of Neuromyelitis Optica Spectrum Disorders, Worldwide, 2019-2029

Sep 25, 2019

Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Insights, Epidemiology and Market Forecasts, 2017-2028

Jul 31, 2019

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Neuromyelitis Optica Spectrum Disorder

Nov 09, 2018

Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Insights, Epidemiology and Market Forecast 2016-2027

Oct 31, 2018

Global Neuromyelitis Optica Spectrum Disorder Epidemiology Forecast Report 2018-2027

Aug 10, 2018

The Guthy-Jackson Charitable Foundation Welcomes Christopher Clinton Conway as Executive Director

Oct 10, 2017

Abide Therapeutics Announces Dosing of First Subject in Phase 1b Study of ABX-1431 in Patients with Neuromyelitis Optica (NMO)